South Wales, Oct. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "HILBARI" on Oct. 7. The details about the trademark application no. UK00004274330 published in the journal no. 2025/042 (Oct. 17).
With Stevens Hewlett & Perkins as representative, Celldex Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of mast-cell mediated disorders; Pharmaceutical preparations for the treatment of urticaria; Pharmaceutical preparations for the treatment of chronic spontaneous urticaria (CSU); Pharmaceutical preparations for the treatment of chronic inducible urticaria (CIndU); Pharmaceutical preparations for the treatment of prurigo nodularis (PN); Pharmaceutical preparations for the treatment of atopic dermatitis (AD); Pharmaceutical preparations for the treatment of cold urticaria (ColdU); Pharmaceutical preparations for the treatment of symptomatic dermographism (SD); Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of inflammatory diseases.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004274330
Disclaimer: Curated by HT Syndication.
